Schedule 13D ownership disclosure

KALOBIOS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 48344T100

Event date: 2015-11-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
70.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-067990
Form type
SC 13D
Filer
HUMANIGEN, INC
CIK
CIK 1293310
Filed
Nov 25, 2015
Reporting period
Nov 16, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub